2014年9月18日（星期四）下午

Thursday Afternoon, Sept.18^th, 2014

Clinical Management of T-Cell Lymphoma in China

Venue: 1E Meeting Room, 1st Floor, Xiamen International Conference Center

Co-Chairs: Yan Sun 孙  燕 院士

           Zhong-Zhen Guan 管忠震

          Zhi-Xiang Shen 沈志祥

          Jun Ma 马  军

SESSION 2

Subject: Emerging new therapies peripheral T-cell lymphoma

Moderators: Jun Zhu 朱  军

           Francine Foss

14:30~15:00  Targeting the epigenome in T-cell lymphoma 

            Susan Bates   National Institutes of Health, USA

15:00~15:30  Emerging new drugs and combinations for T-cell lymphoma  

            Owen O’Connor   Columbia University, USA

15:30~16:00  The role of stem cell transplant in PTCL: One Center’s Perspective  

            He Huang 黄  河   Zhejiang University, China

16:00~16:15  PANEL DISCUSSION  

SESSION 3 

Subject: Regulating new drugs and treatment platforms for T-cell lymphoma

Moderators: Wen-Qi Jiang姜文奇

          Owen O’Connor

16:15~16:45  EU challenges with the EMEA: setting priorities for patients with PTCL

            Christian Gisselbrecht   Hospital Saint Louis, France

16:45~17:15  Drug approval in Asia: Role of The China/Japan/Korea Tripartite Cooperation

            Yok-Lam Kwong 邝沃林   University of Hong Kong, China

17:15~17:45  Cancer Drug Approval in the United States

            Antonio T. Fojo   National Cancer Institutes, USA

17:45~18:00  PANEL DISCUSSION